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Abstract
Background: Spontaneous immortalisation of cultured mammary epithelial cells (MECs) is an extremely rare event,
and the molecular mechanism behind spontaneous immortalisation of MECs is unclear. Here, we report the
establishment of a spontaneously immortalised bovine mammary epithelial cell line (BME65Cs) and the changes in
gene expression associated with BME65Cs cells.
Results: BME65Cs cells maintain the general characteristics of normal mammary epithelial cells in morphology,
karyotype and immunohistochemistry, and are accompanied by the activation of endogenous bTERT (bovine
Telomerase Reverse Transcriptase) and stabilisation of the telomere. Currently, BME65Cs cells have been passed for
more than 220 generations, and these cells exhibit non-malignant transformation. The expression of multiple genes
was investigated in BME65Cs cells, senescent BMECs (bovine MECs) cells, early passage BMECs cells and MCF-7 cells
(a human breast cancer cell line). In comparison with early passage BMECs cells, the expression of senescence-
relevant apoptosis-related gene were significantly changed in BME65Cs cells. P16
INK4a was downregulated, p53 was
low expressed and Bax/Bcl-2 ratio was reversed. Moreover, a slight upregulation of the oncogene c-Myc, along with
an undetectable level of breast tumor-related gene Bag-1 and TRPS-1, was observed in BME65Cs cells while these
genes are all highly expressed in MCF-7. In addition, DNMT1 is upregulated in BME65Cs. These results suggest that
the inhibition of both senescence and mitochondrial apoptosis signalling pathways contribute to the immortality
of BME65Cs cells. The expression of p53 and p16
INK4a in BME65Cs was altered in the pattern of down-regulation
but not “loss”, suggesting that this spontaneous immortalization is possibly initiated by other mechanism rather
than gene mutation of p53 or p16
INK4a.
Conclusions: Spontaneously immortalised BME65Cs cells maintain many characteristics of normal BMEC cells and
exhibit non-malignant transformation. Although this cell line displays altered patterns of gene expression, it is
clearly distinct from malignant breast cancer cell line. It showed that co-inhibition of cellular senescence and
mitochondrial apoptosis pathways coordinates BME65Cs cells immortalisation. Additionally, mechanisms other than
gene mutation are likely to be involved in regulation of cellular functions. This study provides an insight into the
relationship between cell senescence and immortalisation. BME65Cs cells will be useful in future studies of cellular
senescence and tumorigenesis.
Background
In serum-free culture, primary mammary epithelial cells
(MECs) proliferate for 10 ± 20 population doublings
(PD), after which they enter the first growth barrier:
self-selection or M0 also named stasis [1]. Thereafter,
small cells can appear, and these cells proliferate for up
to 40-50 PD, after which they enter the second growth
barrier: replicative senescence or M1, also called “ago-
nescence” [2]. There are few reports of mammary
epithelial cells (especially bovine MECs) spontaneously
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escape senescence and acquire the ability to grow in cul-
ture indefinitely [4]. Whether changes in gene expres-
sion accompany the spontaneous immortalisation of
MECs is unclear, relevant data are available from cancer
cells. It has been known that cellular replicative senes-
cence is triggered by telomere shortening during each
cell division [5]. Telomerase reverse transcriptase
(TERT) maintains telomere length by replicating the tel-
omere tracts and preventing cells from replicative senes-
cence [6]. Overexpression of TERT has been used to
immortalize a variety of normal diploid cell strains [7].
In addition, TERT gene has frequently been activated in
cancer and stem cells [5,8]. The tumor suppressor p53,
which is inactivated in numerous cancer cells due to its
gene mutation [9,10], plays a key role in repressing tran-
scription of TERT gene [11]. Another important tumor
suppressor p16
INK4a, a cyclin-dependent kinase (CDK)
inhibitor, maintains normal cellular properties by pre-
venting both centrosome dysfunction and genomic
instability [12]. In mammary epithelial cells, it has been
suggested that the pre-reduction of p16
INK4a by a direct
or indirect method is required for TERT-mediated
immortalisation [4]. In addition to the negative regula-
tion of p16
INK4a and p53 in the control of cell prolifera-
tion, some proto-oncogene such as c-Myc and others
may help cells to escape senescence control and lead to
carcinogenesis [11,13,14]. However, it is unclear whether
the expression patterns of these cellular oncogenes and
tumor suppressors are altered in immortalized cells and
what is the mechanism for spontaneous immortalization
of MECs.
Immortalised bovine mammary epithelial cell line can
be used as an in vitro screening system to identify
superior transgenes, and to improve genomic modifica-
tion technological research, thereby improving the effi-
ciency of transgenic animal production [15]. In this
study, we described a spontaneously immortalised cell
line (BME65Cs) derived from serial passages of bovine
mammary epithelial cells. We performed a detailed
investigation of cell characteristics and changes in gene
expression in comparison to early passage cells, senes-
cent cells and human mammary cancer cells (MCF-7).
Our data showed that multiple signal pathways are
involved in this process and BME65Cs is distinct from
malignant MCF-7 in cancer associated gene expression.
Results
Spontaneously immortalised BME65Cs cells maintain the
normal morphology and proliferation characteristic of
normal BMECs
The spontaneously immortalised BME65Cs cell line was
established from in vitro cell culture. The initial cell
focus was observed in a culture of BMECs cells when
normal cells had entered the senescence state. This cell
focus had a similar morphology to the early passage
BMECs cells (Figure 1A) and was surrounded by an
annulus of senescent cells (Figure 1C). In serum-con-
taining culture, normal BMECs cells enter replicative
senescence at PDL 34 (Figure 1B), whereas BME65Cs
cells have been passed more than PDL 220. Continuous
observation showed that before PDL 55 BME65Cs had a
doubling time of approximately 48 hours, which was
similar to normal cells. At PDL 55, although some of
these cells become longer and less proliferative, a major-
ity of cells remained epithelial morphology with a dou-
bling time of approximately 72 hours (Figure 1D). This
observation is consistent with the growth rate assay
(Figure 1E and 1F). There was an adjustment phase
required for BME65Cs cells to become a stable cell line.
Interestingly, a small proportion of cells died in each
passage.
BME65Cs cells maintain many characteristics of normal
mammary epithelial cells
The breast epithelial compartment comprises two dis-
tinct lineages: the luminal epithelial and the myoepithe-
lial lineage. It has been suggested that in vitro,n o r m a l
luminal epithelial cells from the human mammary gland
immunostain for CK18 (mammary epithelial cell specific
marker protein cytokeratin 18), ESA (epithelial specific
antigen) and MUC-2 (mucin 2 glycoprotein) [16],




[16,17]. To test if BME65Cs cells are originated from the
luminal epithelial or from myoepithelial, BME65Cs cells
were immunostained with these three antibodies. The




accordance with normal BMECs. Moreover, BME65Cs,
similar to normal BMEC, showed a very slight signal in
the staining of CK14, a maker of myoepithelial cells [1]
(Figure 2).
Cell cycle and apoptosis are very important functional
parameters used to assess cellular metabolism and phy-
siology. We determined the cell cycle distribution of
BME65Cs, early passage (PDL 12) and late passage (PDL
28) BMECs by flow cytometry. As shown in Figure 3A,
growth arrest in the G0/G1 and G2/M phases was
observed in late BMECs, but not in BME65Cs and early
passage BMECs. Moreover, the proportion of cells in
the S phase was increased in BME65Cs cells (PDL 102),
but significantly decreased in late passage cells com-
pared to early passage BMECs cells, suggesting that
BME65Cs cell line has a higher proliferative capacity
than that of normal cells.
To identify senescent state, a senescence marker,
senescence-associated b-galactosidase (SA-b-gal), was
examined in BME65Cs (PDL 87) as well as the control
BMECs (PDL 28 and PDL 7). SA-b-gal staining was
Zhao et al. BMC Cell Biology 2010, 11:82
http://www.biomedcentral.com/1471-2121/11/82
Page 2 of 13Figure 1 Cell morphology and cell growth rate of BME65Cs cells. A. Phase-contrast images of in vitro cultivated, early passage BMECs cells
(PDL 10) with typical morphologies. B. Senescent BMECs cells (PDL 34) with an increased size. C. The initially isolated population of immortalised
epithelial-like cells (BME65Cs). D. BME65Cs cells (PDL 120) with the typical cobblestone pattern of freshly isolated primary BMECs cells. Bars: 50
μm. E. Growth curve of BME65Cs and BMECs cells. To determine growth rates, primary (PDL 2) and immortal mammary epithelial cells (PDL 41)
were plated at a density of 3 × 10
5 cells/10 cm dish using culture conditions as described above. At 80% confluency, cells were trypsinised and
subcultured every two days, and cumulative population doublings based on cell numbers was calculated. Normal BMECs cells entered the
senescent state at PDL 34, and spontaneously immortalised BME65Cs colonies were generated at this stage. F. Growth rates of primary BMECs
cells (PDL 5) and immortal BME65Cs cells (PDL 120). Cells were plated at a density of 1 × 10
5 cells/10 cm dish for over 6 days of continuous
culture, and cell numbers were counted each day. A similar increase in growth rate was observed between early passage MECs and
immortalised BME65Cs cells.
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Page 3 of 13observed in late passage BMECs cells (PDL 28) and was
not observed in early passage BMECs cells (PDL 7). As
expected, approximately 10% of BME65Cs cells (PDL
87) stained for SA-b-gal (Figure 3B), consistent with the
culture observation. This suggests that some of the
immortalised BME65Cs cells still undergo senescence in
normal culture conditions.
The growth of BME65Cs cells in serum-containing
medium is dependent on the supplementation of insulin,
epidermal growth factor and hydrocortisone, displaying
normal BMECs cell growth characteristics. In compari-
son, the breast cancer cell line MCF-7 and the pre-
viously reported OMEC II (ovine immortal MECs) grow
very rapidly in serum-containing medium without any
further additives [18]. To determine whether immorta-
lised BME65Cs cells have cancer cell potential, the soft
agar assay for colony formation was performed. No col-
ony was formed in BME65Cs (PDL 110) and normal
BMECs (PDL 20), while obvious colony formation in
MCF-7 is obvious (Figure 4A). Furthermore, the cell-cell
contact in BME65Cs cells induced growth arrest (data
not shown). These results together suggested that
BME65Cs cells had a normal growth characteristic of
anchor dependency and no tendency for malignant
transformation [19].
To understand the cytogenetic property of the
BME65Cs cell line, twenty-one metaphase spreads of
PDL 110 were examined. Nineteen of them maintained
normal female karyotype (60, XX), and only two cells
appeared abnormal with 61, XX karyotype (Figure 4B).
This differed from OMEC II, in which 3-4% of the cells
were heteroploid at an earlier stage (PDL 5) and 25% at
passage 60 [18]. Thus, the karyotype analysis indicated
that the BME65Cs cell line has stable cytogenetic
properties.
Telomere length was stabilised without further
elongation in BME65Cs cells
TERT expression is thought to be an important factor
for cellular immortalization [20]. To confirm whether
endogenous bTERT is activated during immortalisation
of BME65Cs cells, the expression of bTERT mRNA was
Figure 2 Immunostaining of specific mammary epithelial cell protein markers. Staining for CK18, ESA, MUC-2, and CK14 were observed in
BMECs and BME65Cs cells, whereas staining for the isotype controls was faint (small pictures in bottom- right corner). PI was added as an
immunofluorescence counterstain. Bars: 20 μm.
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Page 4 of 13detected by RT-PCR. As expected, bTERT was obviously
transcribed in BME65Cs cells (PDL 104) but silenced in
control BMECs cells (PDL 5 and 22) (Figure 5A).
Next, telomere lengths were further assayed by south-
ern hybridisation. The mean telomere length of terminal
restriction fragments (TRFs) in BME65Cs cells (PDL
104) is 18.7 kb. Comparatively, TRFs in BMECs cells at
PDL 5 and PDL 22 are 17.9 and 6.4 kb, respectively
(Figure 5B). This result suggests that telomere length is
maintained in the BME65Cs cell line.
Gene expression profile was changed in BME65Cs cells
Cells that undergo immortalisation escape the controls
of senescence and apoptosis. In order to gain insight
into possible pathways involved in the BME65Cs cell
line immortalisation, we selected 34 genes regulated
mainly at the level of transcription to investigate the
differences in gene expression between BME65Cs cells,
senescent BMECs cells and early passage BMECs cells,
as well as the MCF-7 cell line. Analysis of transcription
profiles indicated that transcription levels of several
genes, which are important for cell survival and growth,
are significantly altered in BME65Cs comparing to the
early passage BMECs (Figure 6).
It is well known that p16
INK4a and p53 are important
for cellular apoptosis and senescence. Thus, we initially
examined changes in expression of these two genes.
Both p16
INK4a and p53 are significantly changed (8 fold
decrease) in BME65Cs cells, indicating the importance
of p16
INK4a and p53 signalling pathways in immortalisa-
tion of the BME65Cs cell line. Moreover, in senescent
BMECs cells the expression of p16
INK4a was unchanged,
but there was a slight change in p53 (2 fold decrease),
suggesting there is no correlation between the
Figure 3 Analysis of cell cycle and cell senescence-associated b-galactosidase activity in BME65Cs and BMECs cells. A. Cell cycle analysis
of BME65Cs cells (passage 102), BMECs cells primary passage 12 and 28 was performed using flow cytometry of propidium iodide-stained cells. A
similar proportion of cells in S phase were observed in immortalised BME65Cs cells and early passage BMECs cells. B. Early passage 7, BMEC cells
senescent passage 28 and immortal BME65Cs cells passage 87 were stained for b-galactosidase activity. Cells were fixed and incubated with X-
gal. Blue staining indicates the presence of senescence associated b-galactosidase. This illustrates that a portion of immortalised BME65Cs cells
(PDL 87) were in the senescent state. Bars: 20 μm.
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Page 5 of 13expression of p53 and p16
INK4a. In MCF-7 cells, expres-
sion of both genes is undetectable (Row2-3 in Figure 6).
As the p53 protein is frequently absent in cancer cells
[9,10], we investigated p21
cip1, one of the downstream
targets of p53 that functions in cell cycle regulation
[21], to enhance the result of p53. Paralleling the
expression of p53, an undetectable signal of p21
cip1was
observed in both BME65Cs cells and MCF-7 cells,
whereas a slight change (0.75 fold decrease) was
observed in senescent cells (Row 4).
Next, we examined Bcl-2 family genes. Bcl-2 and Bax
act crucial roles in the mitochondrial apoptosis pathway
by suppressing and improving apoptotic cell death,
respectively [22-25]. Expression of Bcl-2 mRNA was
unchanged in BME65Cs cells and was slightly downre-
gulated (0.75-fold) in senescent BMECs cells compared
to early passaged BMECs cells, whereas expression of
Bcl-2 was significantly lower (0.25 fold) in MCF-7 cells
(Row 5). Bax mRNA was upregulated (2.5 fold) in
senescent BMECs cells and downregulated (4 fold) in
MCF-7 cells. Notably, Bax mRNA was not detected in
BME65Cs cells (Row 6). Moreover, expression of
another anti-apoptotic Bcl-2 family gene, Bag-1 [26],
was unchanged in the three non-cancer cells. As shown,
Bag-1 was undetectable in early passaged cells, senescent
BMECs cells and BME65Cs cells, whereas there was
high expression in MCF-7 cells (Row 7). Thus, the
expression of Bcl-2, Bax and Bag-1 in BME65Cs cells
was different from expression in MCF-7 cells. These
results suggest that the immortalisation of the BME65Cs
line involved inhibition of the mitochondrial apoptosis
pathway.
To further understand the difference between sponta-
neously immortalised MECs and breast cancer cells, we
Figure 4 Soft agar assay and karyotype analysis in immortal BME65s cells and early passage BMECs cells. A. Analysis of colony
formation used for evaluating malignant potential by the soft agar assay. Colonies containing more than ten viable cells were scored positive.
Obvious colony formation was shown in MCF-7 cells, which served as a positive control. Bars: 50 μm. B. Comparison of chromosome numbers.
At least 20 well-spread metaphase chromosomes from immortal BME65Cs cells (passage 110) and BMECs cells (primary passage16) were
examined and the characteristic patterns illustrated were observed.
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Page 6 of 13investigated the expression of other genes considered to
be differentially expressed or highly expressed in breast
cancer cells. Two genes, TRPS-1 and c-Myc [27,14], dis-
played the difference. TRPS-1 expression was undetect-
able in both BME65Cs cells and early passage BMECs
cells, which significantly distinguished from the high
expression in MCF-7 cells. However, a low expression
of TRPS-1 was shown in senescent cells (Row 8). Simi-
larly, expression of c-Myc was almost undetectable in
early passage and senescent BMECs cells. Although a
low level of expression was detected in BME65Cs cells,
by contrast, c-Myc was highly expressed in MCF-7 cells,
about 200 fold higher than in BME65Cs cells (Row 9).
Therefore, in addition to Bag-1, the expression level of
c-Myc and TRPS-1 in BME65Cs cells was also markedly
different from that in MCF-7 cells.
To understand the possible changes of DNA methyla-
tion that may cause altered gene expression in
BME65Cs cells, we examined three DNA methyltrans-
ferases genes: DNMT1, DNMT2 and DNMT3. A signifi-
cant difference was found for DNMT1.A ss h o w n ,
DNMT1 mRNA was upregulated in BME65Cs cells (3
fold), MCF-7 cells (4 fold) and senescent cells (2 fold).
DNMT1 (DNA methyltransferase 1) is primarily a main-
tenance methylase, which reproduces DNA methylation
patterns from hemimethylated DNA during cell division
[28]. DNMT1 protein is disproportionately overex-
pressed in the S-phase fraction of estrogen receptor-
negative cancer cell lines, including the MCF-7 line [29].
Thus, the upregulation of DNMT1 in the BME65Cs cell
line suggests a possible change in DNA methylation.
Discussion
We have established a spontaneously immortalised
mammary epithelial cell line, BME65Cs. This cell line
exhibits the majority of normal MECs features, whereas
growth character, the ability to form colonies and
expression of relevant breast tumor genes are signifi-
cantly different from breast cancer cells (MCF-7). These
data suggest that BME65Cs cells are not derived from
malignant transformations. Whether or not in vitro
spontaneous transformation is correlated with in vivo
benign tumor transformation, the immortal BME65Cs
cell line will be a useful tool for studying the molecular
mechanism of tumorigenesis and cellular senescence. In
contrast, TERT or SV40 gene mediated immortalization
by the random integration of exogenous genes may
bring an unforeseeable influence on natural gene expres-
sion and regulation.
There are three types of human mammary epithelial
cell progenitors have been identified. The first is
thought to be a luminal-restricted progenitor; the sec-
ond type is a bipotent progenitor which is identified by
its ability to produce “mixed"colonies in single cell
Figure 5 Detection of bTERT expression and analysis of
telomere length in BME65Cs and BMECs cells. A. The detection
of bTERT mRNA by RT-PCR. The bovine catalytic subunit of
telomerase (bTERT) mRNA levels from primary early passage 5,
BMECs cells senescent passage 22 and immortal BME65Cs cells
passage 104 were determined by RT-PCR using sequence-specific
primer pairs. b-actin was used as a loading control. B. Southern-blot
analysis of mean telomeric length. Genomic Southern-blot analysis
was performed to determine the telomeric lengths of primary early
passage 5 and senescent passage 22 BMECs as well as immortal
BME65Cs cells passage 104. The DNA marker (l DNA/Hind III) was
used to determine the telomere length of various samples.
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Page 7 of 13assays; the third type of progenitor is thought to be
myoepithelial restricted progenitor because it only pro-
duces cells with myoepithelial features [30]. In this
study, a part of normal cultured BMECs show a basal
(myoepithelial) markers (CK14
+) coinciding with the




- and no “mixed” population
are found, which suggests BME65Cs is not derived from
myoepithelial cell or bipotent progenitor. Although
BME65Cs maintains many characters of luminal cells
with stable proliferation behaviour over the long period
of culture, it is unclear whether BME65Cs derived from
a luminal epithelial lineage or from a progenitor cell
with the capacity for luminal.
Transcriptional analysis of multiple genes sheds light
on the number of genes involved in the immortalisation
of BME65Cs cells. An interesting question raised by the
data is the following: what are the main factors that
contribute to initiation of the BME65Cs cells immortali-
sation? There are two signaling pathways, p16
INK4a-pRb
and p53-p21, that are mainly responsible for the control
of cellular senescence [12,31]. The tumor suppressor
Figure 6 Relative genes expression of early passage senescent BMECs, BME65Cs and MCF-7 cells. A.T h ed e t e c t i o no fr e l a t i v eg e n e s
expression by RT-PCR. B. Analysis of expression level by gray scale. The expression level of each gene in BMECs cells (PDL 14) was set to 1.0. The
expression level for TRPS-1, Bag-1 and c-Myc in MCF-7 cells was set to 1.0 because these three genes expressions were not detected in BMECs
cells (PDL 14)]. Other samples were adjusted accordingly. All PCR products were confirmed by sequencing. Gray scale analysis is from at least 3
independent experiments. *: P < 0.05 compared to BMECs cells passage 14 (Student’s t-test). **: P < 0.01 compared to BMECs cells passage 14
(Student’s t-test).
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INK4a and p53 are frequently inactivated in
cancer cells; inhibition of them escapes cellular senes-
cence leading to tumorgenesis [31,32]. In this study, a
significant change (but not loss) of p16
INK4a and p53
were found in BME65Cs cells, suggesting that the inhi-
bition of senescent-relevant pathways contributes to the
BME65Cs cell line immortalisation. Additionally, the
p16
INK4a -pRb pathway is thought to control the first
growth barrier (self-selection) of MECs [1], and downre-
gulation of p16
INK4a is required for the TERT-mediated
immortalisation of MECs [4]. Therefore, downregulation
of p16
INK4a is likely to be one of the key factors asso-
ciating to BME65Cs cells immortalisation. However,
t h e r ei sn oe v i d e n c es u g g e s t ing that inactivation or
downregulation of p16
INK4a alone can induce immortali-
sation of MECs. Thus, changes in expression of other
genes may also be involved in the initiation of
BME65Cs cells immortalisation. Although the absence
of p53 is thought to be an important initial factor for
numbers of cancers, and several genes in the Bcl-2
family are regulated by p53 [9,24,31], it is unclear what
the cause for the shortage of p53 expression (compare
to normal cell) in BME65Cs cells. It has been known
that telomere shortening and DNA damage activate p53
expression [21,24]. Thus, the maintenance of telomere
length in BME65Cs cells may be the one reason for low
expression level of p53. There remains a discrepancy
between the relationship of p53 and p16
INK4a.I nm o s t
cancer cells, p16
INK4a and p53 are two-independent sig-
nalling pathways [33]. However, one report suggests that
p16
INK4a regulates p53 in human mammary epithelial
cells [34]. Despite this, the low expression of p53 might
contribute to the coordination of BME65Cs cells
immortalisation, because p53 plays a role in transcrip-
tional repression of TERT [11]. Together, we speculate
that the low expression of both p16
INK4a and p53 is
important for the maintenance of BME65Cs cells
immortalisation.
Overexpression of TERT protects telomere repeats
from erosion and, consequently, from induction of repli-
cative senescence or apoptosis [35]. Thus, expression of
bTERT may be another important factor for immortali-
sation of BME65Cs cells. TERT is positively regulated by
c-Myc [36], but negatively regulated by p53 [11]. There-
fore, the low expression of p53 and upregulation of
c-Myc in BME65Cs cells might contribute to the activa-
tion of bTERT, and expression of bTERT may subse-
quently lead to stable telomere length in BME65Cs cells,
aiding cells in overcoming senescence and leading to
immortalisation. As a transcriptional factor, c-Myc is
believed to regulate the expression of 15% of all genes,
including genes involved in cell division, cell growth,
and apoptosis [37]. In addition to the high expression in
a number of cancer cells, c-Myc is also expressed in
stem cells, and is thought to be a requirement for the
maintenance of stemness [38]. Hence, we presume that
the function pattern of cell linage-specific regulation of
c-Myc might be dependent on its expression level. Cur-
iously, the detection of TRF length shows discontinuity
in BME65Cs. We suppose that it might be due to some
non-immortal cells existing in BME65Cs, since some
BME65Cs still died in each passage and showed SA-b-
gal positive. It is interest to point out that the telomere
length in BME65Cs is similar to that in early passage
BMECs, this suggests immortalisation event for
BME65Cs might occur in early passage cell.
In addition to c-Myc, two other genes, TRPS-1 and
Bag-1, are also highly expressed in MCF-7 cells but
undetectable in BME65C cells. TRPS-1 is called tricho-
rhino-phalangeal syndromes type 1 gene, which muta-
tions are previously shown to be associated with three
rare autosomal dominant genetic disorders known as
the tricho-rhino-phalangeal syndromes (TRPS). Recently,
TRPS-1 protein has been found to be dramatically over-
expressed in >90% of early and late-stage breast cancers
[27]. Bag-1 is a multifunctional protein that interacts
with a wide range of cellular targets and regulates cell
survival, signaling, metastasis, proliferation and tran-
scription [26,39]. In breast cancer, overexpression of
Bag-1 has been detected in a majority of cases [40].
T a k e nt o g e t h e r ,t h ee x p r e s s i o no fTRPS-1 and Bag-1
m a yb eu s e dt oe v a l u a t em a l i g n a n to rn o n - m a l i g n a n t
transformation of immortalised MECs. However, low
expression of TRPS-1 was detected in senescent BMECs
cells, implying that expression of TRPS-1 could be regu-
lated by the cellular growth state, and TRPS-1 protein
probably has other function that differs from its func-
tion in cancer cells.
Bcl-2 and Bax are important oncoproteins involved in
regulation of cellular apoptosis via the mitochondrial
apoptosis pathway. Bcl-2 functions in suppressing cell
apoptosis, whereas Bax promotes cell apoptosis [23,41].
Paradoxically, expression of Bcl-2 has been consistently
associated with a better prognosis of breast cancer
patients [41-43]. It has been suggested that the Bax/Bcl-
2 ratio determines whether apoptosis will occur [24]. In
this study, Bax is deficient in BME65Cs cells, whereas
Bcl-2 is highly expressed. Hence, immortalisation of
BME65Cs cells is also accompanied by the inhibition of
the mitochondrial apoptosis pathway. Interestingly,
expression of another member of the Bcl-2 family, Bag-
1, is undetectable in three different bovine MECs
including BME65Cs cells and excluding MCF-7 cells.
Although we have analysed changes in expression of
several genes from different cell strains, it is unclear
what the initial mechanism is responsible for the change
of these genes. Based on the fact that both p16
INK4a and
p53-p21 are low expressed but not silenced in BME65Cs
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during immortalisation. In addition, epigenetic control is
another important mechanism in regulation of genes
expression. Abnormal DNA methylation patterns have
been shown in a number of cancer cells [44]. Overex-
pression of DNMT1 has been detected in several human
cancers [45-47]. Carcinogenesis is often accompanied by
increases of DNMT1 mRNA, DNMT1 protein, and
DNA methyltransferase activity [48-50]. Moreover, epi-
g e n e t i cc h a n g eh a sb e e ns h o w nt h ei m p o r t a n tr o l ei n
immortalisation of human MECs [51,52]. In this study,
DNMT1 is significantly increased in BME65Cs cells and
highly expressed in MCF-7 cells, suggesting that DNA
methylation status is likely to be linked to immortalisa-
tion. Whether the epigenetic changes conclusively lead
to the altered expression of “immortalisation-initial
genes” in BME65Cs cells requires further investigation.
Conclusions
During the spontaneous immortalisation of mammary
epithelial cells, BME65Cs cells undergo changes in gene
expression. These changes improve cellular proliferation
and may not contribute to malignant potential. The
bTERT activation accompanied by the alternation of
gene expression in multi-pathways contributes to
BME65Cs immortalisation. In addition, changes in
expression of immortalisation-related genes are likely to
be controlled by some mechanisms other than gene
mutation, such as DNA methylation. This study pro-
vides an insight into the relationship between cellular
senescence and immortalisation. However, more
research is required to provide a more detailed mechan-
ism for the initiation of BME65Cs cells immortalisation.
Regardless, this spontaneous immortal cell line will be a
useful tool for studying cell molecular biology, in addi-
tion to the investigation of mammary gland specific
expression and somatic gene targeting technology.
Methods
Cell culture
Mammary gland tissues were obtained from a normal
two-year old Chinese Holstein dairy cattle in lactation
period by surgical operation. Several small pieces of tis-
sue were carefully dissected from the inner part of the
large mammary gland tissue, and enzymatically digested
by a combination of trypsin, hyaluronidase (sigma) and
collagenase (sigma) to separate breast epithelial and
ductal tissue from stromal cellular components. Cells
were planted in serum-containing medium: DMEM-F12
supplemented with 10% iron-supplemented fetal cattle
serum, 5 μg of insulin per ml, 10 ng of epidermal
growth factor per ml, 0.5 μg of hydrocortisone per ml,
and 100 units/ml penicillin and streptomycin. Digested
cells were cultured at 37°C in a CO2 incubator. The
primary BMECs cells were passaged at a 1: 8 split, and
thus each passage represented three population dou-
blings. Population doublings (PD) were calculated by the
following equation: PD = [ln (split ratio)/ln2]. The
population doubling level (PDL) resulted as the cumula-
tive PD. BMECs cells displaying typical cobblestone
morphology were subcultured at or near confluence,
and the cumulative PDL was recorded. Immortalised
BME65Cs cells were derived from cultured cell over
PDL 34 and continuously cultured in the same medium.
MCF-7 cells were cultured in DMEM medium supple-
mented with 10% iron-supplemented fetal cattle serum.
Cell growth assay
To determine growth rates, primary and immortal mam-
mary epithelial cells (PDL 41) were plated at a density of
3×1 0
5 cells/10 cm dish using culture conditions as
described above. At 80% confluency, cells were trypsi-
nised and subcultured every two days, and cumulative
population doublings based on cell numbers was calcu-
lated. Cell growth was also determined by plating cells
at a density of 1 × 10
5 cells/10 cm dish using conditions
described above, and cells were counted each day for up
to 6 days to determine cell numbers.
Indirect immunofluorescent staining
BMECs (PDL 12), BME65Cs (PDL 125) and fibroblast
cells (PDL 10) were seeded in gelatin-coated chamber
slides. Cells were fixed and permeabilised by addition of
3% paraformaldehyde for 30 minutes, followed by incu-
bation with 0.3% Triton X-100 in PBS for 20 min. After
blocking with 10% FCS in PBS, cells were incubated
with the mouse anti-human cytokeratin 14 (CK14) anti-
body, the mouse anti-human cytokeratin 18 (CK18)
antibody, the epithelial specific antigen (ESA) antibody
and the mucin 2 glycoprotein monoclonaly (MUC-2)
antibody, respectively, followed by incubation with the
secondary antibody (goat anti-mouse IgG-fluorescein
isothiocyanate (FITC)-conjugated antibody, Sigma).
Thereafter, 1.5 mM PI was added as a counterstain for
immunofluorescence and incubated with cells in the
dark for 5 minutes at room temperature. The mouse
IgG3, IgG1 and IgG2a were used as isotype controls,
respectively. Specific fluorescence was detected by using
a laser confocal microscope.
Flow cytometric analysis
BMECs cells at PDL 12 and PDL 28, and BME65Cs cells
(PDL 102) were plated at 10
5 cells/well on 35mm plates
in corresponding medium. Cultured cells were washed
with PBS solution and trypsinised, then fixed in an etha-
nol (80%)/PBS solution at 4°C for 30 min. Thereafter,
cells were incubated in a solution containing 0.2 mg/ml
RNase at 37°C for 30 minutes and stained with 50 ng/ml
Zhao et al. BMC Cell Biology 2010, 11:82
http://www.biomedcentral.com/1471-2121/11/82
Page 10 of 13propidium iodide at room temperature for 30 minutes,
and analysed by flow cytometry (FACScaliber; Becton
Dickinson, San Jose, CA).
Senescence-associated b-galactosidase assay (SA-b-gal)
BMECs cells at PDL 7 and PDL 28, and BME65Cs cells
(PDL 87) were washed with PBS and fixed for 5 minutes
at room temperature with 3% formaldehyde. Subse-
quently, staining was performed with X-gal solution (1
mg/mL X-gal, 0.12 mM K4Fe [CN]6,0 . 1 2m MK 3 F e
[CN]6,1m MM g C l 2 i nP B Sa tp H6 . 0 )f o r1 2 ha t3 7 ° C
and then washed with PBS and photographed.
Soft agar assay
Soft agar assays were performed in duplicates using 300
cells/cm
2 as previously described [19]. MCF-7 cells were
used as a positive control. The ability for anchorage-
independent growth shown by clone formation was ana-
lysed after three weeks. Clones containing more than
ten viable cells were scored as positive.
Chromosomal analysis
Metaphase chromosomes were prepared from BMECs
cells (PDL 16) and BME65Cs cells (PDL 110), and grown
on plastic plates. Logarithmically growing cells were
arrested in metaphase using colcemid (sigma) (100 ng/ml),
trypsinised, incubated for 30 minutes in 75 mM KCl, fixed
with methanol:acetic acid (3:1), dropped onto cold glass
slides and stained with Giemsa (sigma). At least 20 well
spread metaphases chromosomes from cultures were
examined to obtain the characteristic patterns illustrated.
Terminal restriction fragment (TRF) analysis
The mean telomere length was evaluated by using TRF
analysis, a variation of standard Southern analysis, and
was quantified. Genomic DNA was extracted from
BME65Cs cells (PDL 104), BMECs cells at PDL 5 and
PDL 22. Two micrograms of DNA was digested with
a Hinf I/Rsa I mixture (10 U each) and separated on a
0.6% agarose gel by electrophoresis. To ascertain that
a comparable amount of DNA from individual cells was
loaded in each lane, the gel was stained with ethidium
bromide and examined by UV light. The gel was then
depurinated for 15 min in 0.25 M HCl, denatured for
20-30 min in 0.4 M NaOH and transferred to a nylon
membrane using 0.4 M NaOH as the transferring buffer.
After rinsing in 2×SSC and neutralisation solution,
hybridisation was performed overnight at 65°C using a
specific biotinylated detection telomere probe, then
washed twice (5 minutes each time) in 2×SSC/0.1%
sodium dodecyl sulfate (SDS) at room temperature and
o n et i m ef o r1 5m i n u t e si n0 . 2 × S S C / 0 . 1 %S D S .T h e
Luminescence Detection Kit (Roche) was used to detect
TRF DNA on Hyperfilm. The size (in kilobases) of the
mean telomere length was determined by comparing the
migration distance with fragments of known DNA
markers.
Real-time PCR measurements of relative mRNA levels
mRNA was collected from early passage (BMECs PDL
14), senescent (BMECs PDL 32) and spontaneously
immortalised (BME65Cs PDL 104) mammary epithelial
cells, as well as MCF-7 cells. Total cellular RNAs were
extracted with an RNA extraction kit (Tiangen Co.) and
5 μg of total RNA from each sample was used for reverse
transcription. One microliter of reverse transcription
product was used as template for PCR amplification.
Relative quantification was evaluated by calculating the
ratios of copy numbers between target genes and the
reference b-actin gene (a housekeeping gene). Primer
pairs used for the analysis are displayed in Table 1. Con-
sidering the mRNA and protein levels in eukaryotic cells
Table 1 Primer pairs used in the real-time PCR experiments of gene expression profiles Primer pairs applied for real-
time PCR
Gene Accession Sense primer Antisense primer Product
bTERT NM001046242 TCACGGGTCAAGACGCTGT CGGGCATAACTGGAGTGGT 886 bp
p16
INK4a XM868375 GGTGATGATGATGGGCAGCG ACCAGCGTGTCCTGGAAGC 134 bp
p53 NM174201 CGGAACACCTTTAGACACAGT GTAGGCAGTGCTCGCTTAGT 304 bp
p21
Cip1 NM001098958 TCTACCACTCCAAACGCA GCAAAGGATGAAGAGGGTT 331 bp
TRPS-1 NM014112* GCCTTCTTTGAGTTCGGA CCCTCTGCTGTTTGTTGAG 384 bp
Bcl-2 XM586976 GCCTTCTTTGAGTTCGGA TTCAGAGACAGCCAGGAGA 209 bp
Bax NM173894 AGTGGCGGCTGAAATGTT TTCTTCCAGATGGTGAGCG 287 bp
Bag-1 NM001076291 TGCCATTGTCAGCACTTG TGTTCTGTTCCACTGTGTCAC 376 bp
c-Myc AF519455 GTGTCTACCCATCAGCACAA AACTGTTCTCGCCTCTTCTG 376 bp
DNMT1 NM182651 CCCGAGTGTGGAAAGTGTA GAACATCTGCCCATTGCT 392 bp
*TRPS-1 primer pairs were designed by comparing homologous sequences between the Homo sapiens and Bos taurus genome, because the cattle TRPS-1
sequence has not been reported.
All other primer sequences were cited from GenBank. Each pairs of primers span intron-extron boundaries.
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between mRNA and protein shown in previous reports
were selected for detection (data not shown).
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